Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The no-reflow phenomenon in the young and in the elderly.
Cenko E, Ricci B, Kedev S, Kalpak O, Câlmâc L, Vasiljevic Z, Knežević B, Dilic M, Miličić D, Manfrini O, Koller A, Dorobantu M, Badimon L, Bugiardini R. Cenko E, et al. Among authors: vasiljevic z. Int J Cardiol. 2016 Nov 1;222:1122-1128. doi: 10.1016/j.ijcard.2016.07.209. Epub 2016 Aug 2. Int J Cardiol. 2016. PMID: 27499222 Clinical Trial.
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study.
Mrdovic I, Savic L, Perunicic J, Asanin M, Lasica R, Marinkovic J, Vasiljevic Z, Ostojic M. Mrdovic I, et al. Among authors: vasiljevic z. J Interv Cardiol. 2009 Aug;22(4):320-8. doi: 10.1111/j.1540-8183.2009.00476.x. Epub 2009 Jun 8. J Interv Cardiol. 2009. PMID: 19515084 Free article.
Impact of high post-loading platelet aggregation on 30-day clinical outcomes after primary percutaneous coronary intervention. The antiplatelet regimen tailoring after primary PCI (ART-PCI) trial.
Mrdovic I, Savic L, Krljanac G, Asanin M, Perunicic J, Antonijevic N, Lasica R, Marinkovic J, Kocev N, Vasiljevic Z. Mrdovic I, et al. Among authors: vasiljevic z. Int J Cardiol. 2013 Aug 20;167(4):1632-7. doi: 10.1016/j.ijcard.2012.04.129. Epub 2012 May 22. Int J Cardiol. 2013. PMID: 22626838 Clinical Trial.
Exploring in-hospital death from myocardial infarction in Eastern Europe: from the International Registry of Acute Coronary Syndromes in Transitional Countries (ISACS-TC); on the Behalf of the Working Group on Coronary Pathophysiology & Microcirculation of the European Society of Cardiology.
Bugiardini R, Manfrini O, Majstorović Stakić M, Cenko E, Boytsov S, Merkely B, Becker D, Dilic M, Vasiljevic Z, Koller A, Badimon L. Bugiardini R, et al. Among authors: vasiljevic z. Curr Vasc Pharmacol. 2014;12(6):903-9. doi: 10.2174/157016111206141210122150. Curr Vasc Pharmacol. 2014. PMID: 23607683
Unfractionated heparin-clopidogrel combination in ST-elevation myocardial infarction not receiving reperfusion therapy.
Bugiardini R, Dorobantu M, Vasiljevic Z, Kedev S, Knežević B, Miličić D, Calmac L, Trninic D, Daullxhiu I, Cenko E, Ricci B, Puddu PE, Manfrini O, Koller A, Badimon L; ISACS-TC Investigators. Bugiardini R, et al. Among authors: vasiljevic z. Atherosclerosis. 2015 Jul;241(1):151-6. doi: 10.1016/j.atherosclerosis.2015.04.794. Epub 2015 Apr 27. Atherosclerosis. 2015. PMID: 25988359
Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes.
Bugiardini R, Cenko E, Ricci B, Vasiljevic Z, Dorobantu M, Kedev S, Vavlukis M, Kalpak O, Puddu PE, Gustiene O, Trninic D, Knežević B, Miličić D, Gale CP, Manfrini O, Koller A, Badimon L. Bugiardini R, et al. Among authors: vasiljevic z. Am J Cardiol. 2016 Mar 1;117(5):760-7. doi: 10.1016/j.amjcard.2015.11.059. Epub 2015 Dec 13. Am J Cardiol. 2016. PMID: 26778165 Free article. Clinical Trial.
135 results